Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma brucei | cytochrome P450, putative | 0.003 | 0.059 | 1 |
Mycobacterium ulcerans | beta-ketoacyl synthase-like protein | 0.027 | 1 | 1 |
Mycobacterium ulcerans | cytochrome P450 108B4 Cyp108B4 | 0.0016 | 0.0063 | 0.0063 |
Mycobacterium ulcerans | cytochrome P450 185A4 Cyp185A4 | 0.003 | 0.059 | 0.059 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0035 | 0.0798 | 1 |
Mycobacterium ulcerans | cytochrome P450 143A4 Cyp143A4 | 0.0016 | 0.0063 | 0.0063 |
Mycobacterium tuberculosis | Probable cytochrome P450 132 Cyp132 | 0.0016 | 0.0063 | 0.0063 |
Mycobacterium ulcerans | cytochrome P450 123A3 Cyp123A3 | 0.0016 | 0.0063 | 0.0063 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.003 | 0.059 | 0.3288 |
Mycobacterium ulcerans | cytochrome P450 144A4 Cyp144A4 | 0.0016 | 0.0063 | 0.0063 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.006 | 0.1794 | 1 |
Mycobacterium ulcerans | cytochrome P450 136A2 Cyp136A2 | 0.0016 | 0.0063 | 0.0063 |
Mycobacterium ulcerans | cytochrome P450 140A5 Cyp140A5 | 0.0016 | 0.0063 | 0.0063 |
Schistosoma mansoni | hypothetical protein | 0.0016 | 0.0063 | 1 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.003 | 0.059 | 0.3288 |
Mycobacterium tuberculosis | Probable cytochrome P450 138 Cyp138 | 0.0016 | 0.0063 | 0.0063 |
Trichomonas vaginalis | ap endonuclease, putative | 0.0015 | 0 | 0.5 |
Brugia malayi | Cytochrome P450 family protein | 0.003 | 0.059 | 0.3288 |
Toxoplasma gondii | cytochrome p450 superfamily protein | 0.0016 | 0.0063 | 1 |
Brugia malayi | Cytochrome P450 family protein | 0.003 | 0.059 | 0.3288 |
Trichomonas vaginalis | ap endonuclease, putative | 0.0015 | 0 | 0.5 |
Mycobacterium ulcerans | cytochrome P450 187A5 Cyp187A5 | 0.0016 | 0.0063 | 0.0063 |
Brugia malayi | Cytochrome P450 family protein | 0.006 | 0.1794 | 1 |
Schistosoma mansoni | cytochrome P450 | 0.0016 | 0.0063 | 1 |
Mycobacterium ulcerans | cytochrome P450 126A3 Cyp126A3 | 0.0016 | 0.0063 | 0.0063 |
Leishmania major | cytochrome p450-like protein | 0.0016 | 0.0063 | 0.1068 |
Mycobacterium tuberculosis | Probable cytochrome P450 monooxygenase 142 Cyp142 | 0.0016 | 0.0063 | 0.0063 |
Loa Loa (eye worm) | CYP4Cod1 | 0.003 | 0.059 | 0.3288 |
Plasmodium falciparum | beta-ketoacyl-ACP synthase III | 0.027 | 1 | 1 |
Mycobacterium tuberculosis | Possible cytochrome P450 135A1 Cyp135A1 | 0.0016 | 0.0063 | 0.0063 |
Leishmania major | cytochrome p450-like protein | 0.0016 | 0.0063 | 0.1068 |
Wolbachia endosymbiont of Brugia malayi | 3-oxoacyl-ACP synthase | 0.027 | 1 | 1 |
Trypanosoma brucei | Lanosterol 14-alpha demethylase | 0.0016 | 0.0063 | 0.1068 |
Mycobacterium leprae | putative cytochrome p450 | 0.0016 | 0.0063 | 0.5 |
Giardia lamblia | Endonuclease/Exonuclease/phosphatase | 0.0015 | 0 | 0.5 |
Mycobacterium ulcerans | cytochrome P450 189A7 Cyp189A7 | 0.0016 | 0.0063 | 0.0063 |
Leishmania major | cytochrome p450-like protein | 0.003 | 0.059 | 1 |
Brugia malayi | Cytochrome P450 family protein | 0.0016 | 0.0063 | 0.0351 |
Mycobacterium ulcerans | cytochrome P450 124A1, Cyp124A1 | 0.0016 | 0.0063 | 0.0063 |
Mycobacterium tuberculosis | Probable cytochrome P450 137 Cyp137 | 0.0016 | 0.0063 | 0.0063 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0035 | 0.0798 | 1 |
Trypanosoma cruzi | cytochrome p450-like protein, putative | 0.0016 | 0.0063 | 0.1068 |
Mycobacterium tuberculosis | Probable cytochrome P450 124 Cyp124 | 0.0016 | 0.0063 | 0.0063 |
Treponema pallidum | exodeoxyribonuclease (exoA) | 0.0015 | 0 | 0.5 |
Mycobacterium tuberculosis | Cytochrome P450 51 Cyp51 (CYPL1) (P450-L1A1) (sterol 14-alpha demethylase) (lanosterol 14-alpha demethylase) (P450-14DM) | 0.0016 | 0.0063 | 0.0063 |
Echinococcus multilocularis | 0.0016 | 0.0063 | 1 | |
Entamoeba histolytica | fatty acid elongase, putative | 0.0035 | 0.0798 | 1 |
Echinococcus granulosus | cytochrome P450 2K1 | 0.0016 | 0.0063 | 1 |
Mycobacterium ulcerans | cytochrome P450 51B1 Cyp51B1 | 0.0016 | 0.0063 | 0.0063 |
Mycobacterium tuberculosis | Probable cytochrome P450 130 Cyp130 | 0.0016 | 0.0063 | 0.0063 |
Loa Loa (eye worm) | cytochrome P450 | 0.0016 | 0.0063 | 0.0351 |
Mycobacterium tuberculosis | Probable cytochrome P450 139 Cyp139 | 0.0016 | 0.0063 | 0.0063 |
Mycobacterium tuberculosis | Probable cytochrome P450 141 Cyp141 | 0.0016 | 0.0063 | 0.0063 |
Mycobacterium leprae | Conserved hypothetical protein | 0.0016 | 0.0063 | 0.5 |
Mycobacterium ulcerans | cytochrome P450 125A7 Cyp125A7 | 0.0016 | 0.0063 | 0.0063 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0035 | 0.0798 | 1 |
Mycobacterium ulcerans | 3-oxoacyl-ACP synthase | 0.027 | 1 | 1 |
Plasmodium vivax | beta-ketoacyl-acyl carrier protein synthase III precursor, putative | 0.027 | 1 | 1 |
Mycobacterium tuberculosis | Probable cytochrome P450 136 Cyp136 | 0.0016 | 0.0063 | 0.0063 |
Mycobacterium ulcerans | cytochrome P450 142A3 Cyp142A3 | 0.0016 | 0.0063 | 0.0063 |
Mycobacterium tuberculosis | Probable cytochrome P450 125 Cyp125 | 0.0016 | 0.0063 | 0.0063 |
Mycobacterium ulcerans | cytochrome P450 105Q4 Cyp105Q4 | 0.0016 | 0.0063 | 0.0063 |
Mycobacterium tuberculosis | Probable cytochrome P450 144 Cyp144 | 0.0016 | 0.0063 | 0.0063 |
Trypanosoma cruzi | cytochrome P450, putative | 0.003 | 0.059 | 1 |
Mycobacterium ulcerans | cytochrome P450 191A3 Cyp191A3 | 0.0016 | 0.0063 | 0.0063 |
Mycobacterium ulcerans | cytochrome P450 143A3 Cyp143A3 | 0.0016 | 0.0063 | 0.0063 |
Leishmania major | lanosterol 14-alpha-demethylase, putative | 0.0016 | 0.0063 | 0.1068 |
Trypanosoma cruzi | Lanosterol 14-alpha demethylase | 0.0016 | 0.0063 | 0.1068 |
Mycobacterium ulcerans | cytochrome P450 188A3 Cyp188A3 | 0.0016 | 0.0063 | 0.0063 |
Mycobacterium ulcerans | 3-oxoacyl-ACP synthase | 0.027 | 1 | 1 |
Mycobacterium ulcerans | cytochrome P450 187A4 Cyp187A4 | 0.0016 | 0.0063 | 0.0063 |
Mycobacterium tuberculosis | Cytochrome P450 121 Cyp121 | 0.0016 | 0.0063 | 0.0063 |
Mycobacterium tuberculosis | Possible cytochrome P450 126 Cyp126 | 0.0016 | 0.0063 | 0.0063 |
Brugia malayi | cytochrome P450 | 0.0016 | 0.0063 | 0.0351 |
Trypanosoma cruzi | cytochrome P450, putative | 0.003 | 0.059 | 1 |
Mycobacterium tuberculosis | Probable cytochrome P450 143 Cyp143 | 0.0016 | 0.0063 | 0.0063 |
Mycobacterium tuberculosis | Probable cytochrome P450 140 Cyp140 | 0.0016 | 0.0063 | 0.0063 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0035 | 0.0798 | 1 |
Trypanosoma cruzi | Lanosterol 14-alpha demethylase | 0.0016 | 0.0063 | 0.1068 |
Mycobacterium ulcerans | cytochrome P450 150A6 Cyp150A6 | 0.0016 | 0.0063 | 0.0063 |
Mycobacterium tuberculosis | Possible cytochrome P450 135B1 Cyp135B1 | 0.0016 | 0.0063 | 0.0063 |
Mycobacterium tuberculosis | 3-oxoacyl-[acyl-carrier-protein] synthase III FabH (beta-ketoacyl-ACP synthase III) (KAS III) | 0.027 | 1 | 1 |
Mycobacterium ulcerans | cytochrome p450 150 cyp150 | 0.0016 | 0.0063 | 0.0063 |
Mycobacterium tuberculosis | Probable cytochrome P450 123 Cyp123 | 0.0016 | 0.0063 | 0.0063 |
Mycobacterium tuberculosis | Probable cytochrome P450 128 Cyp128 | 0.0016 | 0.0063 | 0.0063 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (binding) | = 99.3 % | Inhibition of human aromatase using androstenedione as substrate assessed as remaining estrone level at 10 uM after 30 mins by LC-MS/MS analysis relative to control | ChEMBL. | 24630560 |
CD100 (functional) | > 100 uM | Cytotoxicity against human PANC1 cells in nutrient deprived medium after 24 hrs | ChEMBL. | 17950610 |
CD100 (functional) | > 100 uM | Cytotoxicity against human PANC1 cells in nutrient deprived medium after 24 hrs | ChEMBL. | 17950610 |
IC50 (functional) | > 100 uM | Cytotoxicity against human A549 cells after 72 hrs by MTT assay | ChEMBL. | 18440233 |
IC50 (functional) | > 100 uM | Cytotoxicity against human HeLa cells after 72 hrs by MTT assay | ChEMBL. | 18440233 |
IC50 (functional) | > 100 uM | Cytotoxicity against human HT1080 cells after 72 hrs by MTT assay | ChEMBL. | 18440233 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
2 literature references were collected for this gene.